Related Experiment Video
Updated: Jun 17, 2026
07:47
Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Antivirulence drugs to target bacterial secretion systems
1Université de Montréal, Département de biochimie, Montréal, Québec, Canada. christian.baron@umontreal.ca
Current Opinion in Microbiology
|January 19, 2010
Summary
Antibiotic resistance is a growing public health threat. This review explores antivirulence drugs targeting bacterial secretion systems as a promising alternative to traditional antibiotics, aiming to disarm pathogens instead of killing them.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Antibiotic resistance in pathogenic bacteria poses a significant global health risk.
- Environmental bacteria act as reservoirs for antibiotic resistance genes, predicting future increases in pathogen resistance.
- Novel strategies are essential for identifying new antibiotic targets and alternatives.
Purpose of the Study:
- To review recent advancements in developing antivirulence drugs as alternatives to classical antibiotics.
- To highlight the potential of targeting bacterial secretion systems to disarm pathogens.
Main Methods:
- Review of current scientific literature on antivirulence drug development.
- Focus on strategies targeting bacterial secretion systems, particularly type III secretion systems.
- Analysis of the potential of antivirulence drugs to combat antibiotic resistance.
Main Results:
- Significant progress has been made in developing antivirulence drugs.
- Type III secretion systems, common in Gram-negative pathogens, are a key target.
- Antivirulence drugs offer a strategy to disarm, rather than kill, bacteria.
Conclusions:
- Antivirulence drugs targeting bacterial secretion systems represent a promising alternative or supplement to conventional antibiotics.
- These drugs disarm pathogens, potentially mitigating the impact of antibiotic resistance.
- Further development in this area is crucial for future infectious disease management.
Related Concept Videos
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:28Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
01:28Biological Methods for Microbial Control
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:12Bacterial Toxins
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...